Increased β‐site APP cleaving enzyme 1‐mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment-Reference-Cited by-同舟云学术

Increased β‐site APP cleaving enzyme 1‐mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment

Published:2021-01-07 Issue:7 Volume:17 Page:1097-1108
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Bao Hong¹,Liu Yiming¹,Zhang Mengguo¹,Chen Zuolong¹,Zhang Weiwei²,Ge Yuhao²,Kang Dongmei²,Gao Feng¹²,Shen Yong¹²³

Affiliation:

1. Neurodegenerative Disorder Research Center Division of Life Sciences and Medicine University of Science and Technology of China Hefei China

2. Institute on Aging and Brain Disorders First Affiliated Hospital of University of Science and Technology of China Hefei China

3. Center for Excellence in Brain Science and Intelligence Technology Chinese Academy of Sciences Shanghai China

Funder

Chinese Academy of Sciences

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12276

Reference48 articles.

1. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective

2. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

3. Insulin Resistance in Cognitive Impairment

4. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies

5. Cognitive function, dementia and type 2 diabetes mellitus in the elderly

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bilingual Nanobiosensor for Cross‐Category Integrated Decoding of the Beta‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1–Aβ Oligomer Signaling Pathway;Small Structures;2024-07-10

2. Association between new‐onset atrial fibrillation and dementia among individuals with type 2 diabetes;Diabetes, Obesity and Metabolism;2024-06-14

3. Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease;Acta Neuropathologica;2024-06

4. Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

5. A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications;Heliyon;2024-03